v3.25.2
Net Loss per Share (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2025
Dec. 31, 2024
Earnings Per Share [Abstract]    
Summary of Basic and diluted net loss per share attributable to common stockholders
Basic and diluted net loss per share attributable to common stockholders for the three months ended June 30, was calculated as follows (in thousands, except share and per share amounts):
 
    
Three Months Ended
June 30,
 
    
2025
    
2024
 
Numerator:
     
Net loss
   $ (7,585    $ (6,259
Less: accretion of Preferred Stock
   $ 3,149      $ 2,908  
  
 
 
    
 
 
 
Net loss attributable to common stockholders — basic and diluted
   $ (10,734    $ (9,167
  
 
 
    
 
 
 
Denominator:
     
Weighted-average common stock outstanding
     1,411,649        980,803  
  
 
 
    
 
 
 
Weighted-average Series A convertible preferred outstanding
     994,869        994,869  
  
 
 
    
 
 
 
Net loss per share attributable to common stockholders — basic and diluted
  
$
(4.46
  
$
(4.64
  
 
 
    
 
 
 
Net loss per share attributable to Series A stockholders — basic and diluted
  
$
(4.46
  
$
(4.64
  
 
 
    
 
 
 
 
Basic and diluted net loss per share attributable to common stockholders for the six months ended June 30, was calculated as follows (in thousands, except share and per share amounts):
 
    
2025
    
2024
 
Numerator:
     
Net loss
   $ (13,662    $ (28,573
Less: accretion of preferred stock
   $ 6,200      $ 5,759  
  
 
 
    
 
 
 
Net loss attributable to common stockholders — basic and diluted
   $ (19,862    $ (34,332
  
 
 
    
 
 
 
Denominator:
     
Weighted-average common stock outstanding
     1,410,811        980,803  
  
 
 
    
 
 
 
Weighted-average Series A convertible preferred outstanding
     994,869        994,869  
  
 
 
    
 
 
 
Net loss per share attributable to common stockholders — basic and diluted
  
$
(8.26
  
$
(17.38
  
 
 
    
 
 
 
Net loss per share attributable to Series A stockholders — basic and diluted
  
$
(8.26
  
$
(17.38
  
 
 
    
 
 
 
 
Summary Of Computation Of Diluted Net Loss Per Share Attributable To Common Stockholders [Table Text Block]   The Company excluded potentially dilutive securities from the computation of diluted net loss per share attributable to common stockholders for the period presented because including them would have had an anti-dilutive effect:
 
    
As of June 30,
 
    
2025
    
2024
 
Series B Convertible preferred stock (as converted to common stock)
     239,156,361        239,156,361  
Series C Convertible preferred stock (as converted to common stock)
     398,512,768        398,512,768  
Series Seed Convertible preferred stock (as converted to common stock)
     71,428,571        71,428,571  
Contingently issuable ordinary shares pursuant to Hutchmed share subscription agreement
     —         140,636,592  
Stock options to purchase common stock
     158,575,852        141,325,852  
  
 
 
    
 
 
 
Total
  
 
867,673,552
 
  
 
991,060,144